Infectious Disease
Hadron Advanced Biosystems files nine biodefense provisional patent applications
Published in Vaccine Weekly, July 3rd, 2002
Hadron, Inc.'s (HDRN) Advanced Biosystems, Inc. subsidiary filed nine provisional patent applications with the U.S. Patent and Trademark Office. These provisional patent applications cover novel treatments of anthrax and filovirus infections, a new approach for the identification of smallpox drug candidates, a medical device design with many potential uses including for cancer treatment and biodefense, and a new use of biodefense research for possible cancer treatment.
The United States Army Research Command supported three of the nine patent applications. Hadron Advanced Biosystems is exploring opportunities to license its technology to, or seek a joint venture with,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2002-07-03)
More Articles from Vaccine Weekly
- Cancer Therapy
Vaccines targeting carcinoembryonic antigen under investigation - Melanoma
Gene expression improves success of melanoma vaccine - Hepatitis Vaccine
Hepatitis B vaccine less effective in chronic hepatitis C patients - Influenza
Information can aid flu vaccination rate among cystic fibrosis patients - Sexually Transmitted Disease
Intranasal vaccine provokes strong immune response in murine model of STD - Agreements
PER.C6 license signed with MedImmune - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
